Vanrx attends Interphex with growing aseptic filling workcell adoption
Vanrx is exhibiting at Interphex 2017 with growing momentum for the adoption of its Aseptic Filling Workcells, the world's first gloveless robotic isolator for fill-finish.

Vanrx Pharmasystems attends Interphex 2017 with growing momentum

March 6, 2017 - News

Vanrx Pharmasystems comes to exhibit at Interphex 2017 with growing adoption of its SA25 Aseptic Filling Workcell. The system is the first gloveless robotic isolator for aseptic filling of injectable drug products.

Singota Solutions (Booth #1461) publicly announced their adoption of Vanrx’s aseptic filling systems, with other U.S. and global installations also occurring this year. Consultations have occurred between Vanrx, customers and regulatory bodies, including the U.S. Food and Drug Administration (FDA), for the use of the Vanrx SA25 in clinical and commercial production.

“Vanrx is growing at a tremendous rate as the industry recognizes the value of the company’s approach to flexible aseptic filling. This edition of Interphex is special because we have so much to share with companies that were waiting to see progress towards product and regulatory milestones,” says Chris Procyshyn, CEO, Vanrx Pharmasystems.

Visitors to booth #3904 can see the SA25 Workcell in operation through the company’s innovative virtual reality experience. Viewers go inside a real Workcell as robots perform the work of filling and closing nested, pre-sterilized vials.

Vanrx will also participate in IPS’ technology tours for the first time as part of the “aseptic small-scale / modular technologies” segment on March 22 at 10 a.m. and 1 p.m.

The SA25 Aseptic Filling Workcell uses robotics to perform all material handling, filling and container closing activities. It was designed by pharmaceutical veterans who wanted to solve long-standing aseptic processing problems within conventional fill-finish systems. Their goal was to make the production of complex drug products easier and improve patient safety.

Key benefits of the SA25 Workcell include:

  • Flexibility to fill and close vials, syringes or cartridges with industry-leading quality.
  • Efficient production of multiple products through fast changeover and batch cycling times.
  • Shortens time to construct filling operations or add capacity through a standardized design.
  • Scale production through additional Workcells to support flexible manufacturing capacity.
  • Lowers costs by using less space and requiring fewer utilities than conventional systems.
  • Use of nested components and closures simplifies material handling and minimizes particle generation

About Vanrx Pharmasystems

Vanrx Pharmasystems makes the most technologically advanced sterile filling solutions for the pharmaceutical industry. Vanrx fill-finish machines use isolated robotics and machine vision to automate the packaging of injectable drugs into nested vials, syringes, or cartridges. The company was founded by pharmaceutical industry veterans to create the systems needed to make the next generation of innovative therapies. For more information, visit

Contact Vanrx

To schedule media interviews with CEO Chris Procyshyn or request a meeting, please contact:

Eric Petz
Senior Marketing Manager
Vanrx Pharmasystems
Phone: +1.778.228.4177

Articles you may want to read

Vanrx Microcell wins Interphex 'Best in Show' award

Vanrx Pharmasystems’ Microcell Vial Filler has won the ‘Best in Show’ award at Interphex 2018, which "recognizes accomplishments and display in the use of knowledge, innovation, and state-of-the-art technologies to achieve extraordinary levels of quality, production goals, and objectives.”

Go to article

Vanrx Microcell wins Pharma Manufacturing Innovation Award

Vanrx Pharmasystems’ Microcell Vial Filler was hand-picked by industry magazine Pharmaceutical Manufacturing for a 2018 Pharma Innovation Award. This is the second award presented in 2018 for the Microcell, following its Interphex ‘Best in show’ award in April.

Go to article